Lingzhi Wang

机构：Jishou University, Nanfang Hospital, Ningbo Medical Center Lihuili Hospital, Southern Medical University · ORCID：0000-0001-5585-5426

发表论文 247 篇 · 总被引 9155 次 · h-index 53

代表论文

• Autophagy in cancer development, immune evasion, and drug resistance (2024 · Drug Resistance Updates · 被引 165)
• Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy (2025 · Cytokine & Growth Factor Reviews · 被引 102)
• Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges (2024 · Cancers · 被引 60)
• Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers (2024 · Pharmacological Research · 被引 21)
• Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial (2025 · The Lancet Oncology · 被引 18)
• Blood-Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges (2024 · Preprints.org · 被引 15)